Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses
about
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsTissue signatures influence the activation of intrahepatic CD8(+) T cells against malaria sporozoitesThe March Toward Malaria VaccinesNew gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.The influence of delivery vectors on HIV vaccine efficacyA Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria VaccineHuman Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 HexonIdentification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.Adenovirus with DNA Packaging Gene Mutations Increased Virus Release.Prospects for oral replicating adenovirus-vectored vaccines.The march toward malaria vaccines.Development of replication-deficient adenovirus malaria vaccines.A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.Molecular characterization of pathogenic and nonpathogenic fowl aviadenovirus serotype 11 isolates.Profiling the Targets of Protective CD8+ T Cell Responses to Infection.Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration
P2860
Q26782083-E604932A-0790-4C4D-BB06-68D1AF821313Q26995655-97B0673F-6E97-4903-AAED-5B095E25AB71Q27026412-49E4E5C5-11D2-4F49-B4C9-C2241B3642D5Q28084325-2B61B3B0-A545-4865-9F47-C81E528053DEQ33868760-E123D02B-6225-4834-8CDB-0B74ABED7232Q34077543-399111B0-A658-488F-81DB-CC5A02DF7D6DQ36003208-F1039C2F-AADC-4783-9E5A-1D1F8CDD8C70Q36058021-B7C9AE7C-5648-4672-BA0C-7B076539FF4BQ37123522-D9D80C2C-7B2A-4FB6-BB6C-C25812D7A122Q37539305-6B3FA86B-E9AC-4228-8E49-923F59C189F8Q38109356-E12FF6A5-39FA-4815-9568-A49AED78D602Q38577638-42547515-B64E-48E9-9323-A2E3A17BDA1DQ38949194-C1ED9CE3-8A6E-47D3-809A-CBA5A403F73DQ39441716-7CB7A5EB-0D87-4408-A651-011C07389CACQ40485010-9531C821-DD9C-44F1-B3B9-D5B8628D2A9AQ41693606-3E9895B8-1092-4A6B-A4FE-FFA73CB21425Q58770917-197434B2-B6BA-4723-AA76-F0EAF24D3A12
P2860
Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Modification of Ad5 hexon hype ...... es protective immune responses
@ast
Modification of Ad5 hexon hype ...... es protective immune responses
@en
Modification of Ad5 hexon hype ...... es protective immune responses
@nl
type
label
Modification of Ad5 hexon hype ...... es protective immune responses
@ast
Modification of Ad5 hexon hype ...... es protective immune responses
@en
Modification of Ad5 hexon hype ...... es protective immune responses
@nl
prefLabel
Modification of Ad5 hexon hype ...... es protective immune responses
@ast
Modification of Ad5 hexon hype ...... es protective immune responses
@en
Modification of Ad5 hexon hype ...... es protective immune responses
@nl
P2093
P2860
P1433
P1476
Modification of Ad5 hexon hype ...... es protective immune responses
@en
P2093
C Richter King
Charlie Thomas
Denise L Doolan
Elena Semenova
Joseph T Bruder
Keith Limbach
Maureen E Stefaniak
Melissa Hamilton
Noelle B Patterson
P2860
P304
P356
10.1371/JOURNAL.PONE.0033920
P407
P577
2012-04-05T00:00:00Z